Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Are sex discordant outcomes in COVID-19 related to sex hormones?
Jonathan D. Strope, Cindy H. Chau, William D. Figg
Seminars in Oncology (2020) Vol. 47, Iss. 5, pp. 335-340
Open Access | Times Cited: 56

Showing 1-25 of 56 citing articles:

Diabetes and Covid-19 among hospitalized patients in Saudi Arabia: a single-centre retrospective study
Abdullah Alguwaihes, Mohammed E. Al‐Sofiani, Maram Megdad, et al.
Cardiovascular Diabetology (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 147
Sex and Gender Differences in Lung Disease
Patricia Silveyra, Nathalie Fuentes, Daniel Enrique Rodriguez Bauza
Advances in experimental medicine and biology (2021), pp. 227-258
Closed Access | Times Cited: 103
Contribution of STAT3 to the pathogenesis of COVID-19
Abdollah Jafarzadeh, Maryam Nemati, Sara Jafarzadeh
Microbial Pathogenesis (2021) Vol. 154, pp. 104836-104836
Open Access | Times Cited: 83
The triumvirate of NF-κB, inflammation and cytokine storm in COVID-19
Ali Attiq, Lui Jin Yao, Sheryar Afzal, et al.
International Immunopharmacology (2021) Vol. 101, pp. 108255-108255
Open Access | Times Cited: 80
The role of androgens in COVID-19
Fatemeh Moradi, Behnaz Enjezab, Akram Ghadiri‐Anari
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2020) Vol. 14, Iss. 6, pp. 2003-2006
Open Access | Times Cited: 52
Repurposing the estrogen receptor modulator raloxifene to treat SARS-CoV-2 infection
Marcello Allegretti, Maria Candida Cesta, Mara Zippoli, et al.
Cell Death and Differentiation (2021) Vol. 29, Iss. 1, pp. 156-166
Open Access | Times Cited: 52
ACE2: Its potential role and regulation in severe acute respiratory syndrome and COVID‐19
Mitra Rezaei, Seyed Ali Ziai, Sajad Fakhri, et al.
Journal of Cellular Physiology (2020) Vol. 236, Iss. 4, pp. 2430-2442
Closed Access | Times Cited: 41
Predicting Potential SARS-COV-2 Drugs—In Depth Drug Database Screening Using Deep Neural Network Framework SSnet, Classical Virtual Screening and Docking
Nischal Karki, Niraj Verma, Francesco Trozzi, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 4, pp. 1573-1573
Open Access | Times Cited: 36
Polycystic ovary syndrome and risks for COVID-19 infection: A comprehensive review
Sebastião Freitas de Medeiros, Márcia Marly Winck Yamamoto, Matheus Antônio Souto de Medeiros, et al.
Reviews in Endocrine and Metabolic Disorders (2022) Vol. 23, Iss. 2, pp. 251-264
Open Access | Times Cited: 23
Differences in mortality of cancer patients with COVID-19 in a Brazilian cancer center
Gisele Aparecida Fernandes, Diego Feriani, Ivan Leonardo Avelino França e Silva, et al.
Seminars in Oncology (2021) Vol. 48, Iss. 2, pp. 171-180
Open Access | Times Cited: 32
Sex- or Gender-specific Differences in the Clinical Presentation, Outcome, and Treatment of SARS-CoV-2
Jeannette Wolfe, Basmah Safdar, Tracy E. Madsen, et al.
Clinical Therapeutics (2021) Vol. 43, Iss. 3, pp. 557-571.e1
Open Access | Times Cited: 21
Structural and Functional Analysis of Female Sex Hormones against SARS-CoV-2 Cell Entry
Jorge Alberto Aguilar-Pineda, Mazen Albaghdadi, Wanlin Jiang, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 21, pp. 11508-11508
Open Access | Times Cited: 21
Characterization of raloxifene as a potential pharmacological agent against SARS-CoV-2 and its variants
Daniela Iaconis, Licia Bordi, Giulia Matusali, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 5
Open Access | Times Cited: 15
Transcriptional Differences for COVID-19 Disease Map Genes between Males and Females Indicate a Different Basal Immunophenotype Relevant to the Disease
Tianyuan Liu, Leandro Balzano‐Nogueira, Ana Lleò, et al.
Genes (2020) Vol. 11, Iss. 12, pp. 1447-1447
Open Access | Times Cited: 21
Androgenetic alopecia and COVID ‐19: A review of the hypothetical role of androgens
Hamideh Moravvej, Mohammad Reza Pourani, Moein Baghani, et al.
Dermatologic Therapy (2021) Vol. 34, Iss. 4
Open Access | Times Cited: 18
Cross Talk between COVID-19 and Breast Cancer
Hamendra Singh Parmar, Aakruti Nayak, Pramod K. Gavel, et al.
Current Cancer Drug Targets (2021) Vol. 21, Iss. 7, pp. 575-600
Closed Access | Times Cited: 17
Targeting the intestinal TMPRSS2 protease to prevent SARS-CoV-2 entry into enterocytes-prospects and challenges
Ismail Sami Mahmoud, Yazun Jarrar
Molecular Biology Reports (2021) Vol. 48, Iss. 5, pp. 4667-4675
Open Access | Times Cited: 17
Exploring Drugs and Vaccines Associated with Altered Risks and Severity of COVID-19: A UK Biobank Cohort Study of All ATC Level-4 Drug Categories Reveals Repositioning Opportunities
Yong Xiang, Kenneth Chi-Yin Wong, Hon‐Cheong So
Pharmaceutics (2021) Vol. 13, Iss. 9, pp. 1514-1514
Open Access | Times Cited: 17
Sex hormones and immune system: Menopausal hormone therapy in the context of COVID-19 pandemic
Marina Averyanova, Polina Vishnyakova, S. V. Yureneva, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 10
Exploration of Sex and Age-Based Associations in Clinical Characteristics, Predictors of Severity, and Duration of Stay among COVID-19 Patients at the University Hospital of Saudi Arabia
Rasha Assiri, Asmatanzeem Bepari, Waseemoddin Patel, et al.
Healthcare (2023) Vol. 11, Iss. 5, pp. 751-751
Open Access | Times Cited: 6
Identification of a 14-Gene Prognostic Signature for Diffuse Large B Cell Lymphoma (DLBCL)
Pengcheng Feng, Hongxia Li, Jinhong Pei, et al.
Frontiers in Genetics (2021) Vol. 12
Open Access | Times Cited: 11
Genetically predicted high IGF-1 levels showed protective effects on COVID-19 susceptibility and hospitalization: a Mendelian randomisation study with data from 60 studies across 25 countries
Xinxuan Li, Yajing Zhou, Shuai Yuan, et al.
eLife (2022) Vol. 11
Open Access | Times Cited: 8
Potential Association between the Use of Anabolic Steroids and COVID-19 Infection
Yusuf S. Althobaiti, Mohammad S. Alzahrani, Shahad M. Alhumayani, et al.
Healthcare (2022) Vol. 10, Iss. 2, pp. 196-196
Open Access | Times Cited: 7
Transcriptional differences for COVID-19 Disease Map genes between males and females indicate a different basal immunophenotype relevant to the disease
Tianyuan Liu, Leandro Balzano Nogueira, Ana Lleò, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 10
What’s Testosterone Got to Do with It? A Critical Assessment of the Contribution of Testosterone to Gender Disparities in COVID-19 Infections and Deaths
Abdulmaged M. Traish, Abraham Morgentaler
Androgens Clinical Research and Therapeutics (2021) Vol. 2, Iss. 1, pp. 18-35
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top